Peripheral Nervous System Disease
11
2
2
8
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 8 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 8 completed trials
Clinical Trials (11)
A Phase 3 Study of NTLA-2001 in ATTRv-PN
Study of Inherited Neurological Disorders
A Phase II, Double-Blind Trial of Recombinant Human Nerve Growth Factor for Treatment of HIV-Associated Sensory Neuropathy
The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients
A Phase II/III Double-Blind Study of Amitriptyline and Mexiletine for Painful Neuropathy in HIV Infection
Association Between Focal Dystonia and Complex Regional Pain Syndrome
Nerve Damage in Patients With HIV Infection Who Have Been Treated With Anti-HIV Drugs
Dose-Finding Study of REN-1654 in Patients With Post-Herpetic Neuralgia
Evaluation of Neuromuscular Disease
Positron Emission Tomography to Measure Pain and Pain Control
Intranasal Peptide T in the Treatment of Painful Peripheral Neuropathy of AIDS